CliniMACS® Formulation Unit

CliniMACS® Formulation Unit

Products & Services

Information

The CliniMACS® Formulation Unit expands the processing capabilities of the CliniMACS Prodigy® Platform to include automated sampling of cells and automated formulation to deliver fresh and frozen final cell products. As an accessory of the CliniMACS Prodigy it further reduces hands-on time from sample to final cell product. • Closed, end-to-end automated process from cell sample to cell product • Expands automation to include fresh or frozen final formulation and fill in desired cell concentrations • Customized solutions available to meet your needs
Miltenyi Biotec71Miltenyi Biotec is a global leader in innovating technologies and services for patient-specific cell and gene therapies, turning scientific discoveries into practical treatments for personalized medicine. Having pioneered a groundbreaking method of cell separation, Miltenyi Biotec continues to set industry standards today. With over 35 years of expertise, it supports customers in biomedical discoveries, translating them into clinical applications to enable access to new therapies for patients. Miltenyi Biotec focuses on providing integrated, advanced solutions to address complex challenges in the treatment of cancers, autoimmune diseases, and inherited disorders. Through its Miltenyi Bioindustry division, it provides expert guidance to therapy developers, helping them efficiently and cost-effectively navigate the path from process development to commercialization. Miltenyi Biotec is headquartered in Bergisch Gladbach and has a global team of 4,700 employees across 24 countries.

Log in

See all the content and easy-to-use features by logging in or registering!